32 related articles for article (PubMed ID: 3444384)
1. Activation of macrophages by ether analogues of lysophospholipids.
Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA
Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051
[TBL] [Abstract][Full Text] [Related]
2. Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress.
Dymond M; Attard G; Postle AD
J R Soc Interface; 2008 Nov; 5(28):1371-86. PubMed ID: 18426775
[TBL] [Abstract][Full Text] [Related]
3. In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.
Brunton VG; Workman P
Br J Cancer; 1993 May; 67(5):989-95. PubMed ID: 8388233
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis and biotransformation of ether lipids.
Mangold HK; Weber N
Lipids; 1987 Nov; 22(11):789-99. PubMed ID: 3328026
[TBL] [Abstract][Full Text] [Related]
5. Induction of differentiation of human myeloid leukemia HL-60 cells by novel nonphosphorus alkyl ether lipids.
Honma Y; Kasukabe T; Hozumi M; Akimoto H; Nomura H
Lipids; 1991 Dec; 26(12):1445-9. PubMed ID: 1819748
[TBL] [Abstract][Full Text] [Related]
6. Comparison of selective cytotoxicity of alkyl lysophospholipids.
Vogler WR; Olson AC; Okamoto S; Shoji M; Raynor RL; Kuo JF; Berdel WE; Eibl H; Hajdu J; Nomura H
Lipids; 1991 Dec; 26(12):1418-23. PubMed ID: 1819744
[TBL] [Abstract][Full Text] [Related]
7. Ether lipids in cancer chemotherapy.
Berdel WE; Okamoto S
Keio J Med; 1990 Jun; 39(2):75-8. PubMed ID: 2214502
[TBL] [Abstract][Full Text] [Related]
8. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
Fromm M; Berdel WE; Schick HD; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):916-8. PubMed ID: 3444385
[TBL] [Abstract][Full Text] [Related]
11. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
Storch J; Munder PG
Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Leder GH; Fiebig HH; Wallbrecher E; Winterhalter BR; Löhr GW
Lipids; 1987 Nov; 22(11):958-61. PubMed ID: 3444393
[TBL] [Abstract][Full Text] [Related]
13. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors.
Berdel WE; Fink U; Egger B; Reichert A; Munder PG; Rastetter J
J Natl Cancer Inst; 1981 May; 66(5):813-7. PubMed ID: 6939927
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
